The 10,000 Brains Project
The 10,000 Brains Project advances earlier detection and personalized treatment for people with neurodegenerative diseases. It aggregates clinical, imaging, genomics, and other biomedical data and applies AI and advanced analytics to identify biomarkers and patient subtypes. The initiative is a nonprofit collaboration with researchers, clinicians, and industry partners that translates analytical insights into targeted therapeutic development. Its work spans multiple neurodegenerative disorders and emphasizes earlier diagnosis and precision care informed by large-scale datasets.
The 10,000 Brains Project
The 10,000 Brains Project advances earlier detection and personalized treatment for people with neurodegenerative diseases. It aggregates clinical, imaging, genomics, and other biomedical data and applies AI and advanced analytics to identify biomarkers and patient subtypes. The initiative is a nonprofit collaboration with researchers, clinicians, and industry partners that translates analytical insights into targeted therapeutic development. Its work spans multiple neurodegenerative disorders and emphasizes earlier diagnosis and precision care informed by large-scale datasets.
TL;DR
What they do: Aggregate clinical, imaging, genomics, and biomedical data to apply AI for earlier detection and personalized treatment of neurodegenerative diseases
Organization type: 501(c)(3) nonprofit (10,000 Brains Neuro AI Inc.)
Founded: 2023
Founders / founding CEO: Kathy Harvard, Michael Maynard, Everett Cook; Patrick Brannelly (founding CEO)
Recent funding: Grant announced May 20, 2025 led by Kissick Family Foundation
Company Overview
Problem Domain
Neurodegenerative disease diagnosis, biomarker discovery, patient subtyping, and precision therapeutics
Founded
2023
Industry
Biotechnology
Tech Stack
Funding Track Record
Grant announced May 20, 2025
Investor Signal
“Kissick Family Foundation”